Potassium chloride and Prevymis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium chloride (potassium chloride) and Prevymis (letermovir). Common drug interactions include viral infection among females and thrombocytopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium chloride and Prevymis. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium chloride?

Potassium chloride has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 29,249 Potassium chloride users. Check the latest studies of Potassium chloride.

What is Prevymis?

Prevymis has active ingredients of letermovir. eHealthMe is studying from 1,328 Prevymis users. Check the latest studies of Prevymis.



On Jul, 16, 2026

33 people who take Potassium chloride and Prevymis together, and have interactions are studied.

Potassium chloride and Prevymis drug interactions.

What are the common drug interactions of Potassium Chloride and Prevymis, by gender? *:

female:

  1. Viral infection
  2. Bacterial infection
  3. Blood glucose decreased
  4. Catheter site infection (infection at the site of insertion)
  5. Dizziness
  6. Eye pruritus (eye itching)
  7. Eyelid margin crusting (crusting at the lid margins, generally worse on waking)
  8. Feeling hot
  9. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  10. Impaired healing

male:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
  3. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Plasma cell myeloma (cancer that begins in plasma cells)
  6. Pneumonia
  7. Productive cough
  8. Pyrexia (fever)
  9. Sputum discoloured
  10. Venoocclusive liver disease (small veins in the liver are obstructed)

What are the common drug interactions of Potassium Chloride and Prevymis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Bicytopenia (two parameters from the full blood count are low, the term bicytopenia can be used)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

40-49:

  1. Bacterial infection
  2. Blood glucose decreased
  3. Catheter site infection (infection at the site of insertion)
  4. Dizziness
  5. Eye pruritus (eye itching)
  6. Eyelid margin crusting (crusting at the lid margins, generally worse on waking)
  7. Feeling hot
  8. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  9. Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
  10. Impaired healing

50-59:

  1. Cytomegalovirus infection
  2. Drug ineffective
  3. Drug level increased
  4. Plasma cell myeloma (cancer that begins in plasma cells)

60+:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Death
  3. Insomnia (sleeplessness)
  4. Leukaemia in remission (a decrease in or disappearance of signs and symptoms of blood cancer)
  5. Pericardial effusion (fluid around the heart)
  6. Platelet count decreased
  7. Pleural effusion (water on the lungs)
  8. Pneumonia
  9. Post procedural complication
  10. Pyrexia (fever)

What are the existing conditions these people have? *

  1. Pain: 5 people, 15.15%
  2. Nausea (feeling of having an urge to vomit): 5 people, 15.15%
  3. Immunodeficiency Common Variable: 5 people, 15.15%
  4. Immunodeficiency: 4 people, 12.12%
  5. Diabetes: 4 people, 12.12%
  6. High Blood Pressure: 4 people, 12.12%
  7. Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 4 people, 12.12%
  8. Thrombocytopenia (decrease of platelets in blood): 4 people, 12.12%
  9. Infection: 4 people, 12.12%
  10. Type 2 Diabetes: 3 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium chloride and Prevymis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Potassium chloride and Prevymis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Potassium chloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prevymis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium chloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prevymis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride and letermovir (the active ingredients of Potassium chloride and Prevymis, respectively), and Potassium chloride and Prevymis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: